Assyro AI

At a glance

May 04, 2018

Approved

Brand (NDA)

Application

Not listed

TE code

11

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 04, 2018

    8 yr 3 mo ago

  2. Today

  3. Patent 10780112 expires

    Listed drug product patent expiration.

    Mar 09, 2032

    in 5 yr 10 mo

  4. Patent 10792306 expires

    Listed drug product patent expiration.

    Mar 09, 2032

    in 5 yr 10 mo

  5. Patent 11529368 expires

    Listed drug product patent expiration.

    Mar 09, 2032

    in 5 yr 10 mo

  6. Patent 10646512 expires

    Listed drug product patent expiration.

    Mar 25, 2032

    in 5 yr 10 mo

  7. Patent 9592252 expires

    Listed drug product patent expiration.

    Aug 11, 2032

    in 6 yr 3 mo

  8. Patent 10016504 expires

    Listed drug product patent expiration.

    Sep 10, 2033

    in 7 yr 4 mo

  9. Patent 10918723 expires

    Listed method-of-use patent (U-2310) expiration.

    Sep 10, 2033

    in 7 yr 4 mo

  10. Patent 12083179 expires

    Listed drug product patent expiration.

    Sep 10, 2033

    in 7 yr 4 mo

  11. Patent 8999313 expires

    Listed drug product patent expiration.

    Sep 10, 2033

    in 7 yr 4 mo

  12. Patent 9326969 expires

    Listed method-of-use patent (U-2310) expiration.

    Sep 10, 2033

    in 7 yr 4 mo

  13. Patent 9707297 expires

    Listed drug product patent expiration.

    Sep 10, 2033

    in 7 yr 4 mo

Pharmaceutical detail

Active ingredient

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Strength

7.54GM;140GM;2.2GM;48.11GM;5.2GM;9GM

Dosage form

FOR SOLUTION

Route

ORAL

TE code

Not listed

Application

NDA 209381

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (11)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10780112Mar 09, 2032in 5 yr 10 mo
Product
10792306Mar 09, 2032in 5 yr 10 mo
ProductU-2310
11529368Mar 09, 2032in 5 yr 10 mo
ProductU-2310
10646512Mar 25, 2032in 5 yr 10 mo
Product
9592252Aug 11, 2032in 6 yr 3 mo
ProductU-2310
10016504Sep 10, 2033in 7 yr 4 mo
Product
10918723Sep 10, 2033in 7 yr 4 mo
U-2310
12083179Sep 10, 2033in 7 yr 4 mo
ProductU-2310
8999313Sep 10, 2033in 7 yr 4 mo
Product
9326969Sep 10, 2033in 7 yr 4 mo
U-2310
9707297Sep 10, 2033in 7 yr 4 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.